APETx1 from sea anemone Anthopleura elegantissima is a gating modifier peptide toxin of the human Ether-a-go-go-related potassium channel

被引:46
作者
Zhang, M.
Liu, X.-S.
Diochot, S.
Lazdunski, M.
Tseng, G.-N.
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Physiol, Richmond, VA 23298 USA
[2] Ctr Natl Rech Sci, Inst Pharmacol Mol & Cellulaire, Unit Mixte Rech 6097, Valbonne, France
关键词
D O I
10.1124/mol.107.035840
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the mechanism of action and the binding site of APETx1, a peptide toxin purified from sea anemone, on the human ether-a-go-go-related gene (hERG) channel. Similar to the effects of gating modifier toxins (hanatoxin and SGTx) on the voltage-gated potassium (Kv) 2.1 channel, APETx1 shifts the voltage-dependence of hERG activation in the positive direction and suppresses its current amplitudes elicited by strong depolarizing pulses that maximally activate the channels. The APETx1 binding site is distinctly different from that of a pore-blocking peptide toxin, BeKm-1. Mutations in the S3b region of hERG have dramatic impact on the responsiveness to APETx1:G514C potentiates whereas E518C abolishes the APETx1 effect. Restoring the negative charge at position 518 (methanethiosulfonate ethylsulfonate modification of 518C) partially restores APETx1 responsiveness, supporting an electrostatic interaction between E518 and APETx1. Among the three hERG isoforms, hERG1 and hERG3 are equally responsive to APETx1, whereas hERG2 is insensitive. The key feature seems to be an arginine residue uniquely present at the 514-equivalent position in hERG2, where the other two isoforms possess a glycine. Our data show that APETx1 is a gating modifier toxin of the hERG channel, and its binding site shares characteristics with those of gating modifier toxin binding sites on other Kv channels.
引用
收藏
页码:259 / 268
页数:10
相关论文
共 54 条
[1]   Specificity of charge-carrying residues in the voltage sensor of potassium channels [J].
Ahern, CA ;
Horn, R .
JOURNAL OF GENERAL PHYSIOLOGY, 2004, 123 (03) :205-216
[2]   TOPOLOGY OF THE PORE-REGION OF A K+ CHANNEL REVEALED BY THE NMR-DERIVED STRUCTURES OF SCORPION TOXINS [J].
AIYAR, J ;
WITHKA, JM ;
RIZZI, JP ;
SINGLETON, DH ;
ANDREWS, GC ;
LIN, W ;
BOYD, J ;
HANSON, DC ;
SIMON, M ;
DETHLEFS, B ;
LEE, CL ;
HALL, JE ;
GUTMAN, GA ;
CHANDY, KG .
NEURON, 1995, 15 (05) :1169-1181
[3]   HERG K+ currents in human prolactin-secreting adenoma cells [J].
Bauer, CK ;
Wulfsen, I ;
Schäfer, R ;
Glassmeier, G ;
Wimmers, S ;
Flitsch, J ;
Lüdecke, DK ;
Schwarz, JR .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2003, 445 (05) :589-600
[4]   Molecular movement of the voltage sensor in a K channel [J].
Broomand, A ;
Männikkö, R ;
Larsson, HP ;
Elinder, F .
JOURNAL OF GENERAL PHYSIOLOGY, 2003, 122 (06) :741-748
[5]   Voltage sensor-trapping:: Enhanced activation of sodium channels by β-scorpion toxin bound to the S3-S4 loop in domain II [J].
Cestèle, S ;
Qu, YS ;
Rogers, JC ;
Rochat, H ;
Scheuer, T ;
Catterall, WA .
NEURON, 1998, 21 (04) :919-931
[6]   Solution structure of APETx1 from the sea anemone Anthopleura elegantissima:: A new fold for an HERG toxin [J].
Chagot, B ;
Diochot, S ;
Pimentel, C ;
Lazdunski, M ;
Darbon, H .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 59 (02) :380-386
[7]   Answers and questions from the KvAP structures [J].
Cohen, BE ;
Grabe, M ;
Jan, LY .
NEURON, 2003, 39 (03) :395-400
[8]   A large number of novel Ergtoxin-like genes and ERG K+-channels blocking peptides from scorpions of the genus Centruroides [J].
Corona, M ;
Gurrola, GB ;
Merino, E ;
Cassulini, RR ;
Valdez-Cruza, NA ;
García, B ;
Ramírez-Domínguez, ME ;
Coronas, FIV ;
Zamudio, FZ ;
Wanke, E ;
Possani, LD .
FEBS LETTERS, 2002, 532 (1-2) :121-126
[9]   Molecular architecture of the KvAP voltage-dependent K+ channel in a lipid bilayer [J].
Cuello, LG ;
Cortes, DM ;
Perozo, E .
SCIENCE, 2004, 306 (5695) :491-495
[10]   APETx1, a new toxin from the sea anemone Anthopleura elegantissima, blocks voltage-gated human ether-a-go-go related gene potassium channels [J].
Diochot, S ;
Loret, E ;
Bruhn, T ;
Béress, L ;
Lazdunski, M .
MOLECULAR PHARMACOLOGY, 2003, 64 (01) :59-69